LECTIN-REACTIVE PROFILES OF ALPHA-FETOPROTEIN CHARACTERIZING HEPATOCELLULAR-CARCINOMA AND RELATED CONDITIONS

被引:196
作者
TAKETA, K
SEKIYA, C
NAMIKI, M
AKAMATSU, K
OHTA, Y
ENDO, Y
KOSAKA, K
机构
[1] SHIGEI MED RES HOSP,OKAYAMA,JAPAN
[2] ASAHIKAWA MED COLL,DEPT INTERNAL MED 3,ASAHIKAWA 07811,JAPAN
[3] UNIV TOKYO,CTR HLTH SERV,TOKYO 113,JAPAN
[4] EHIME UNIV,SCH MED,DEPT INTERNAL MED 3,MATSUYAMA,EHIME 790,JAPAN
关键词
D O I
10.1016/0016-5085(90)91034-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Serum alpha-fetoprotein from 146 patients with hepatocellular carcinoma, other malignancies, and benign liver diseases, was fractionated by lectin-affinity electrophoresis coupled with our sensitive detection method of antibody-affinity blotting. Compared with chronic hepatitis and liver cirrhosis, hepatocellular carcinoma was characterized by the increase in proportions of lentil lectin A-reactive alpha-fetoprotein-L3 and erythroagglutinating phytohemagglutinin-reactive alpha-fetoprotein-P4; the yolk sac tumor was characterized by the increase of concanavalin A-nonreactive alpha-fetoprotein-C1, lentil lectin-A-weakly reactive alpha-fetoprotein-L2, erythroagglutinating phytohemagglutinin-strongly reactive alpha-fetoprotein-P5, and Allomyrina dichotoma lectin-nonreactive, slow-migrating alphafetoprotein-Als; and gastrointestinal tumors were characterized by alpha-fetoprotein-C1, alpha-fetoprotein-L2, alpha-fetoprotein-L3, alpha-fetoprotein-P5 and Allomyrina dichotoma-nonreactive alpha-fetoprotein-A1. By combined evaluation of alpha-fetoprotein-L3 and alpha-fetoprotein-P4, hepatocellular carcinoma was discriminated from chronic hepatitis and liver cirrhosis with a sensitivity of 97% at a specificity of 99.7%. Because the alpha-fetoprotein level of the studied cases ranged from 60-1,500,000 ng/mL (60-1,500,000 μg/L), mostly > 200 ng/mL (200 μg/L), additional patients with lower levels of alpha-fetoprotein [16-177 ng/mL (16-177 μg/L) for 16 cases of hepatocellular carcinoma with liver cirrhosis and 28-185 ng/mL (28-185 μg/L) for 17 cases of liver cirrhosis alone] were analyzed for alpha-fetoprotein-L3 and alpha-fetoprotein-P4. The resulting sensitivity for combined evaluation was still as high as 88% at the same high specificity of 99.7%, indicating that the simultaneous analysis of alpha-fetoprotein-L3 and alpha-fetoprotein-P4 is effective in monitoring the evolution of hepatocellular carcinoma in cirrhotic patients. © 1990.
引用
收藏
页码:508 / 518
页数:11
相关论文
共 33 条
[1]  
ALPERT E, 1978, GASTROENTEROLOGY, V74, P856
[2]   FUCOSYLATION OF SERUM ALPHA-FETOPROTEIN IN PATIENTS WITH PRIMARY HEPATOCELLULAR-CARCINOMA [J].
AOYAGI, Y ;
ISEMURA, M ;
YOSIZAWA, Z ;
SUZUKI, Y ;
SEKINE, C ;
ONO, T ;
ICHIDA, F .
BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 830 (03) :217-223
[3]  
AOYAGI Y, 1988, CANCER-AM CANCER SOC, V61, P769, DOI 10.1002/1097-0142(19880215)61:4<769::AID-CNCR2820610422>3.0.CO
[4]  
2-M
[5]   ALPHA-FETOPROTEIN IN NON-NEOPLASTIC HEPATIC DISORDERS [J].
BLOOMER, JR ;
WALDMANN, TA ;
MCINTIRE, KR ;
KLATSKIN, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 233 (01) :38-41
[6]   MICROHETEROGENEITY OF ALPHA-FETOPROTEIN IN PATIENT SERUM AS DEMONSTRATED BY LECTIN AFFINO-ELECTROPHORESIS [J].
BREBOROWICZ, J ;
MACKIEWICZ, A ;
BREBOROWICZ, D .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1981, 14 (01) :15-20
[7]   SERUM-ALPHA-FETOPROTEIN HETEROGENEITY AS A MEANS OF DIFFERENTIATING BETWEEN PRIMARY HEPATOCELLULAR-CARCINOMA AND HEPATIC SECONDARIES [J].
BUAMAH, PK ;
GIBB, I ;
BATES, G ;
WARD, AM .
CLINICA CHIMICA ACTA, 1984, 139 (03) :313-316
[8]  
BUAMAH PK, 1986, CLIN CHEM, V32, P2083
[9]  
KORNFELD K, 1981, J BIOL CHEM, V256, P6633
[10]   ALPHA-FETOPROTEIN MONITORING IN CHINESE PATIENTS WITH CHRONIC HEPATITIS-B VIRUS-INFECTION - ROLE IN THE EARLY DETECTION OF HEPATOCELLULAR-CARCINOMA [J].
LOK, ASF ;
LAI, CL .
HEPATOLOGY, 1989, 9 (01) :110-115